Elizabethkingia anophelis Isolated from Patients with Multiple Organ Dysfunction Syndrome and Lower Respiratory Tract Infection: Report of Two Cases and Literature Review by Shaohua Hu et al.
CASE REPORT
published: 08 March 2017
doi: 10.3389/fmicb.2017.00382
Frontiers in Microbiology | www.frontiersin.org 1 March 2017 | Volume 8 | Article 382
Edited by:
Leonard Peruski,
US Centers for Disease Control and
Prevention, USA
Reviewed by:
Peter Bergman,
Karolinska Institutet, Sweden
Marquita Vernescia Gittens-St.Hilaire,
University of the West Indies,
Barbados
*Correspondence:
Mingxi Wang
mxwang@hqu.edu.cn
Desong Ming
mds6430@126.com
Shicheng Chen
shicheng@msu.edu
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Infectious Diseases,
a section of the journal
Frontiers in Microbiology
Received: 20 November 2016
Accepted: 23 February 2017
Published: 08 March 2017
Citation:
Hu S, Jiang T, Zhang X, Zhou Y, Yi Z,
Wang Y, Zhao S, Wang M, Ming D
and Chen S (2017) Elizabethkingia
anophelis Isolated from Patients with
Multiple Organ Dysfunction Syndrome
and Lower Respiratory Tract Infection:
Report of Two Cases and Literature
Review. Front. Microbiol. 8:382.
doi: 10.3389/fmicb.2017.00382
Elizabethkingia anophelis Isolated
from Patients with Multiple Organ
Dysfunction Syndrome and Lower
Respiratory Tract Infection: Report of
Two Cases and Literature Review
Shaohua Hu 1†, Tao Jiang 1†, Xia Zhang 2, Yajun Zhou 1, Zhengjun Yi 2, Youxi Wang 3,
Sishou Zhao 3, Mingxi Wang 1, 2*, Desong Ming 4* and Shicheng Chen 5*
1 Yun Leung Laboratory for Molecular Diagnostics, School of Biomedical Sciences, Huaqiao University, Xiamen, China,
2Department of Medical Laboratory, Institute of Nanomedicine Technology, Weifang Medical University, Weifang, China,
3Department of Information, Quanzhou First Hospital Affiliated to Fujian Medical University, Fujian, China, 4Department of
Clinical Laboratory, Quanzhou First Hospital Affiliated to Fujian Medical University, Fujian, China, 5Department of Microbiology
and Molecular Genetics, Michigan State University, East Lansing, MI, USA
Elizabethkingia anophelis, originally discovered from Anopheles mosquito gut, is an
emerging pathogen, especially in immunocompromised patients. We isolated two strains
of E. anophelis from two separate patients with multiple organ dysfunction syndrome
and lower respiratory tract infection. In this paper, we reviewed the status of E. anophelis
infection and its antibiotics resistance from reported cases.
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BACKGROUND
Elizabethkingia, a Gram-negative, aerobic, rod-shaped bacterium, belongs to the family
Flavobacteriaceae within the phylum Bacteroidetes. Four species are assigned to this
genus, including Elizabethkingia meningoseptica, E. anophelis, Elizabethkingia miricola, and
Elizabethkingia endophytica, with the first three being considered to be medically important
(Kukutla et al., 2013, 2014; Lau et al., 2015; Breurec et al., 2016). E. anophelis was initially isolated
from the midgut of mosquito Anopheles gambiae in 2011 (Kämpfer et al., 2011). Later, it was found
in the environment (water and soil) and health care settings (Balm et al., 2013; Teo et al., 2013). It
rarely causes infections in healthy people while it is pathogenic to immunocompromised patients
with a high mortality rate (Teo et al., 2013; Lau et al., 2016; https://www.cdc.gov/elizabethkingia/
outbreaks/). The first reported case of E. anophelis infection was meningitis in an 8-day-old girl
delivered by cesarean section in the Central African Republic in 2011 (Frank et al., 2013). It also
caused nosocomial outbreak in two intensive-care units from a hospital in Singapore in 2012 (Teo
et al., 2013). By conventional phenotypic test, an epidemiological survey of bacteremia from five
regional hospitals in Hong Kong (from 2004 to 2013) identified 17 cases of E. anophelis bacteremia
(Lau et al., 2016). E. anophelis was implicated in recent outbreaks of infections in the Midwest
regions. In Wisconsin, 63 confirmed and 4 possible infections were reported between November
1, 2015 and January 11, 2017. Among these cases, a total of 19 deaths (estimated mortality rate,
28%) were found (https://www.dhs.wisconsin.gov/disease/elizabethkingia.htm). At least 10 E.
anophelis infections were reported in Illinois (between January 2014 and April 2016) and one
in Michigan in March 2016 (https://www.cdc.gov/elizabethkingia/outbreaks/). Most patients
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were over 65 years old with serious underlying diseases (https://
www.cdc.gov/elizabethkingia/outbreaks/). We report here two
cases of E. anophelis infection at Quanzhou First Hospital, Fujian,
China.
CASE PRESENTATION
Case 1
An 82-year-old male patient presenting with lethargy in
consciousness, malnutrition, multiple bedsores [an 8 × 10
cm2 at level I (containing a 5 × 6 cm2 at level II) on the
sacrococcygeal region, two 5 × 5 cm2 at level I on the both
heel, two 2 × 2 cm2 at level I on both external malleolus]
was admitted on December 14, 2009. He had a history of
surgery for esophagus cancer at 73 years old, hypertension at
level III, two hospitalizations due to lower respiratory tract
infections (treated by azithromycin, cefoperazone/tazobactam,
levofloxacin, meropenem, linezolid, piperacillin/tazobactam, and
ciprofloxacin) 4 months before this final hospitalization. He
demonstrated expectoration and shortness of breath for 7
days before admission. The blood gas analysis and blood
biochemical test at admission showed respiratory acidosis (pCO2
97 mm Hg, pO2 122 mm Hg), metabolic alkalosis (pH 7.48,
HCO−3 > 60 mmol/L, CO2 36.8 mmol/L), very low blood
K+ (2.1 mmol/L), renal dysfunction (BUN 23.9 mmol/L),
and extremely low Cl− (68.6 mmol/L). He came into deep
coma with BP 58/34 mmHg within 2 h after admission.
Emergency salvage was given, including assisted ventilation,
raising BP by dopamine and L-noradrenaline, supplement
of potassium chloride, and anti-infection treatment with
piperacillin/tazobactam and ciprofloxacin. In the subsequent
2 days, he recovered from coma gradually, but presented
clear sign of lung infection (fever, moist rale sound in both
sides of lower lung lobes, blood WBC 9.8 × 109/L, NEUT
94.61%, CRP 146 mg/L). Diagnoses of shock, multiple organ
dysfunction syndrome (MODS), and lower respiratory tract
infection were made. The infection and the respiratory acidosis
combined with metabolic alkalosis lasted for nearly the whole
52 day-hospitalization. On the 45th day of hospitalization, a
fistula between the esophagus and trachea was found through
gastroscopy and further verified by bronchoscopy. It was treated
with tracheal stenting 2 days later. However, 5 h after post-
tracheal stenting, sudden cardiac arrest occurred, complicated
with a loss of spontaneous breathing, then he went into coma
(combined with dilated pupils and disappeared light reflex of
both sides) again. BP and SpO2 could not be measured while his
pulse and spontaneous breathing returned 5 min after salvage.
BP, SpO2, and light reflex of both pupils returned to normal
gradually within the subsequent 5 h. However, the patient was
still in coma andwas discharged after 7 days at his family’s request
to terminate treatment.
During the hospitalization, the separately or jointed
isolated pathogenic microbes for the lung infection included
Acinetobacter calcoaceticus–Acinetobacter baumannii complex
(7 times isolated from sputum, 7 TIFS), Acinetobacter baumannii
(4 TIFS), Enterobacter cloacae (3 TIFS), Pseudomonas
aeruginosa (2 TIFS), Serratia marcescens (2 TIFS), molds
(2 TIFS), and E. anophelis (7 TIFS) (named as 12012
PRCM). E. anopheles 12012 PRCM was verified by 16S
rRNA gene sequencing (GenBank accession no. KR349263)
of the genomic DNA with the forward primer 27F (5′-
AGAGTTTGATCCTGGCTCAG-3′) and the reverse primer
1492R (5′-GGTTACCTTGTTACGACTT-3′; Lane, 1991).
It was resistant to all the 20 antibiotics in the antibiotic
susceptibility tests (AST) panel, including β-lactams (ampicillin,
piperacillin, ampicillin-sulbactam, piperacillin-tazobactam,
ceftazidime, cefotaxime, cephazolin, cefepime, aztreonam,
imipenem, and meropenem), aminoglycosides (amikacin,
gentamicin), tetracycline, chloramphenicol, and polymyxin,
quinolones (ciprofloxacin, levofloxacin, moxifloxacin), and
sulfamethoxazole-trimethoprim. The strain was also resistant to
another antibiotic amoxicillin-clavulanate tested. To investigate
the resistance mechanisms, extended spectrum β-lactamase
(ESBL) detection was performed on the E. anophelis 12012
PRCM using BD’s PhoenixTM-100 Automated Microbiology
System with the NMIC/ID-4 panel (Becton, Dickinson,
and Company; Stefaniuk et al., 2003; Liu et al., 2005). The
cephalosporin test was positive and the carbapenem-hydrolyzing
β-lactamases and carbapenemases (CHBLs) were detected.
In addition, we found this strain was co-positive between
EDTA (Ethylenediaminetetraacetic acid) and imipenem. These
laboratory findings indicated strain 12012 PRCM could produce
metal-beta-lactamase, possibly conferring the β-lactamases
resistance.
Case 2
A 47-year-old male with hypotension (BP 95/55 mmHg) was
admitted to our hospital on August 21, 2015. He had history of
exacerbated abdominal pain and abdominal distension for more
than 10 days, shortness of breath for 3 days, complicated with
stagnated exhaust and defecation. Before admission, his pressure
was maintained by continuous pumping of L-noradrenaline and
dopamine. Physical examination found weak breath sounds in
both sides of lung lobes and severe subcutaneous edema on
whole body. The arterial blood gas analysis displayed acidosis
(pH 7.20, pCO2 11.1 mmHg, pO2 99 mmHg, HCO
−
3 −8.6
mmol/L, BE −23.3 mmol/L). He had a low white blood cell
count (WBC) (2.35 × 109/L). Blood biochemical test showed
several abnormal results (glucose 8.86 mmol/L, BUN 18.93
mmol/L, creatinine 271 µmol/L, GFR 24.20 ml/min, AST 827
U/L, ALT 197 U/L, albumin 30.5 g/L, T-BIL 29.5 µmol/L, D-BIL
12.8 µmol/L, total osmotic pressure 280 mOsm/L). Ultrasound
imaging demonstrated liver cirrhosis, echo enhancement in
parenchyma of both kidneys and effusion around left renal.
Computed tomography scanning revealed inflammatory changes
within both sides of the lower lung lobes, severe effusion
within bilateral pleural, abdominal, and pelvic cavity, edema
within subcutaneous soft tissue of chest and abdominal wall.
Diagnoses of shock, MODS, electrolyte imbalances (low sodium,
low calcium), diabetes and pulmonary infection were made.
Within 16 h after admission, the patient further presented
oliguria and aggravated during the 12-day hospitalization. On
the 3rd day, hepatic virus infection [with positive HBsAg,
anti-HBe antibody, and anti-HBc antibody (IgG)], abnormal
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blood coagulation [prothrombin time (PT) 16.7 s, partial
prothrombin time (APTT) 67.8 s, fibrinogen (FIB) 1.75 g/L, D-
dimer 8.32 mg/L, international normalized ratio (INR) 1.43], and
thrombocytopenia (84 × 109/L) were diagnosed, with the latter
lasting for the remaining hospitalization. The treatment strategies
included drainage of bilateral pleural effusion, maintaining
blood pressure as previously, improving liver function, daily
hemodialysis, management of electrolyte, insulin injection and
improving nutrition. The empirical antimicrobial therapy was
started with IV piperacillin and tazobactam during the first 3 days
of hospitalization, then changed to IV imipenem and cilastatin
sodium for 1 day and further combined with vancomycin; the
latter lasted for the remaining 8 days of hospitalization. The
patient died of sudden cardiac arrest.
By using BD’s PhoenixTM-100 Automated Microbiology
System with the NMIC/ID-4 panel as Case 1, we repeatedly
isolate E. meningoseptica (on the 7th and 9th day of
hospitalization respectively) and Stenotrophomonas maltophilia
(on the 8th and 9th day of hospitalization respectively) from
sputum cultures. Later, E. meningoseptica was verified as
E. anophels (named as N107618, GenBank accession No.
KX775952) by 16S rRNA gene sequencing as Case 1. E. anophelis
N107618 was resistant to 16 out of 20 antibiotics in the same
AST panel used to test the E. anophelis 12012 PRCM, and was
only susceptible to ciprofloxacin, levofloxacin, moxifloxacin, and
sulfamethoxazole-trimethoprim.
DISCUSSION
E. anopheliswas an opportunistic pathogen but it could result in a
high mortality rate (Teo et al., 2013; Lau et al., 2016; https://www.
cdc.gov/elizabethkingia/outbreaks/). The number of E. anophelis
infections was possibly underestimated because E. anophelis
were often misidentified as E. meningoseptica by conventional
identification methods (Kämpfer et al., 2011; Teo et al., 2013,
2014; Nicholson et al., 2016). Identification of E. anophelis
by the matrix assisted laser desorption-ionization time-of-flight
(MALDI-TOF) mass spectrometry will be helpful if E. anophelis
reference is added in the database (Teo et al., 2013; Lau et al.,
2016). 16S rRNA gene sequencing should be performed as a
routine bacterial identification tool in the medical laboratories
without MALDI-TOF mass spectrometry (Teo et al., 2013; Lau
et al., 2016).
The high mortality rate of E. anophelis infection was partly
due to its property of multidrug-resistance. E. anophelisN107618
was resistant to 16 out of 20 antibiotics while strain 12012 PRCM
was resistant to all the 20 antibiotics in the AST panel, indicating
that our two clinical E. anophelis isolates were multidrug-
resistant. Furthermore, our tests showed that the isolate
E. anophelis 12012 PRCM produced metallo-beta-lactamase(s).
β-lactams resistance has been shown in many clinical important
Elizabethkingia isolates (Frank et al., 2013; Lau et al., 2015,
2016). Notably, all clinical E. anophelis isolates, except for our
strain 12012 PRCM, were susceptible to one or more quinolones
such as ciprofloxacin or moxifloxacin (Frank et al., 2013; Lau
et al., 2015). Therefore, ciprofloxacin or moxifloxacin might
be considered as empirical antibiotic therapy of E. anophelis
infections. For example, Frank et al. reported that a clinical isolate
was resistant to all β-lactams tested (amoxicillin, cefotaxime,
ceftazidime, cefepime, and imipenem) except for piperacillin and
aminoglycosides (amikacin, tobramycin, and gentamicin) while
it was susceptible to moxifloxacin (Frank et al., 2013). Similarly,
three clinical E. anophelis strains were resistant to β-lactams
aminoglycosides, tetracycline, and chloramphenicol while
they were susceptible to pipercillin, cefoperazone-sulbactam,
trimethoprim-sulfamethoxazole, ciprofloxacin, moxifloxacin,
and rifampin (Lau et al., 2015). Moreover, the survey of 17 E.
anophelis bacteremia demonstrated that they were resistant
or intermediate-resistant to imipenem, amikacin, gentamicin,
and tobramycin, but they were susceptible to ceftazidime,
piperacillin, and rifampicin (Lau et al., 2016).
Next generation sequencing (NGS) techniques greatly
contribute to our understanding of drug resistance and
infectivity of E. anophelis. For example, 16 and 19 antibiotic
resistance genes were found from the core and accessory
genomes of E. anophelis, respectively (Teo et al., 2014). The
genome of E. anophelis NUHP1 contained 14 antibiotic resistant
genes that correlated to its multi-drug resistance (Li et al., 2015).
Breurec et al. reported that at least 17 antimicrobial resistance
genes in E. anophelis consisted of metallo-beta-lactamase genes
blablaB and blaGOB (conferring β-lactams resistance), subclass B1
beta-lactamase gene, eﬄux systems, conserved chloramphenicol
acetyltransferase (CAT and AAC3-I) gene, a tetX gene (encoding
for a tetracycline inactivating enzyme) and LinF gene (encoding
lincosamide resistance protein; Breurec et al., 2016). Genome
sequencing analysis showed that E. anophelis processed virulence
genes encoding cell wall hydrolase A, listeriolysin O (LLO),
phospholipase (PlcA), virulence cluster protein B (VclB), and
arylsulfatase (Lau et al., 2015; Breurec et al., 2016). These
virulence factors possibly contribute to the invading of the host,
escape from phagocytosis, surviving in the secondary vacuole of
macrophages, and propagating in bloodstreams (Lau et al., 2015;
Breurec et al., 2016).
CONCLUSION
E. anophelis is an emerging opportunistic pathogen. It often
leads to a high mortality rate because of its multiple
antibiotic resistance. Therefore, E. anophelis infections should
be considered clinically significant. Investigation of antibiotic
resistance mechanisms are warranted.
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